Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion type Assertion NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_head.
- NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion description "[We tested the potential of adeno-associated viral (AAV)-delivered therapeutic microRNAs, targeting the human Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1), to correct myopathic features in mice expressing toxic levels of human FRG1 (FRG1(-high) mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_provenance.
- NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion evidence source_evidence_literature NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_provenance.
- NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion SIO_000772 21730972 NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_provenance.
- NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion wasDerivedFrom befree-2016 NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_provenance.
- NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_assertion wasGeneratedBy ECO_0000203 NP907241.RAV_CCMgOBKLBCbqoOxlVNILY5u1OfABryAYvmFHh3DH0130_provenance.